Sb-656933    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
97Ulcerative colitis2

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 2,269 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00748410
(ClinicalTrials.gov)
January 22, 20095/9/2008Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative ColitisAn Open Label, 7-day Repeat Dose Study to Evaluate the Pharmacodynamics of SB-656933-AAA in Patients With Ulcerative Colitis.Colitis, UlcerativeDrug: SB-656933GlaxoSmithKlineNULLTerminatedN/AN/AAll3Phase 2Netherlands
2EUCTR2007-005520-32-NL
(EUCTR)
01/10/200805/08/2008An open label, 7-day repeat dose study to evaluate the pharmacodynamics of SB-656933-AAA in patients with Ulcerative Colitis.An open label, 7-day repeat dose study to evaluate the pharmacodynamics of SB-656933-AAA in patients with Ulcerative Colitis. ulcerative colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: SB-656933 Tablets
Product Code: SB-656933
GlaxoSmithKline R&D LtdNULLNot RecruitingFemale: yes
Male: yes
Netherlands